Deutsche Bank Ag\ Legend Biotech Corp Transaction History
Deutsche Bank Ag\
- $240 Billion
- Q3 2024
A detailed history of Deutsche Bank Ag\ transactions in Legend Biotech Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 120,869 shares of LEGN stock, worth $4.43 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,869
Previous 120,632
0.2%
Holding current value
$4.43 Million
Previous $5.34 Million
10.24%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding LEGN
# of Institutions
226Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$409 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$275 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$243 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$210 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$185 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.13B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...